Eversept Partners, LP Karuna Therapeutics, Inc. Transaction History

Eversept Partners, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$93.97 - $143.33 $1.5 Million - $2.28 Million	-15,934 Closed	0 $0
Q1 2022 Nov 08, 2023	BUY	$98.9 - $132.37 $1.58 Million - $2.11 Million	15,934 New	15,934 $2.02 Million
Q4 2021 Nov 08, 2023	SELL	$110.64 - $159.4 $1 Million - $1.45 Million	-9,066 Reduced 36.26%	15,934 $2.09 Million
Q4 2021 Feb 14, 2022	SELL	$110.64 - $159.4 $1 Million - $1.45 Million	-9,066 Reduced 36.26%	15,934 $2.09 Million
Q3 2021 Nov 08, 2023	BUY	$101.2 - $125.87 $2.53 Million - $3.15 Million	25,000 New	25,000 $3.06 Million
Q3 2021 Nov 15, 2021	BUY	$101.2 - $125.87 $2.53 Million - $3.15 Million	25,000 New	25,000 $3.06 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.